Sign in to view content

Association Between Provider Anti-VEGF Injection Rates and Visual Outcome In Eyes With Neovascular Age-Related Macular Degeneration

Michael M. Lai, MD, PhD

Video
Published 2024

Related

Episode 15: Serum VEGF Levels in the IVAN Trial with Dr. Usha Chakravarthy
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
A Phase 1, Multicenter, Prospective, Open-Label, Dose Escalation Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), in Subjects With Wet AMD
Vrinda S. Hershberger, MD, PhD
On Demand Cases, Courses, and Papers
2021
Presumed Silicone Oil Droplets
Rahul N. Khurana, MD, FASRS
Updates from the Field
2017

Category: AMD-Neovascular

Wet AMD

See more